Catalyst
Slingshot members are tracking this event:
Clovis Oncology (CLVS) Presented Rubraca (Rucaparib) And Lucitanib Data At 2021 ASCO Annual Meeting
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CLVS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 08, 2021
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rucaparib, Lucitanib, Rubraca
